Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Trellis Bioscience Inc. logo — Our human mAb TRL1068 disrupts bacterial biofilm and makes t...

Trellis Bioscience Inc.

Our human mAb TRL1068 disrupts bacterial biofilm and makes traditional antibiotics work again overcoming drug resistance

Founded 1998 United States Redwood City, United States 18 employees Grant Total: $28.58M Biotechnology, Health Care +1

General Information

Company Name Trellis Bioscience Inc.
Founded Year 1998
Location United States Redwood City, United States
Employees 18
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Trellis Bioscience Inc.. To contact Trellis Bioscience Inc., visit trellisbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Trellis Bioscience Inc. compare?

A PDF of Trellis Bioscience Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Trellis Bioscience Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Trellis Bioscience Inc.

Trellis Bioscience is a biotechnology startup pioneering cellular informatics to enhance and quantify therapeutic antibody treatments on a single cell level. The company, founded in 1998, offers a technology platform focused on cellular informatics, with a cell biology platform that provides a direct readout at the single cell level. This platform is pivotal in the discovery and production of therapeutic monoclonal antibodies. Trellis Bioscience's innovative technology allows for monitoring the activity of diverse cell types and quantifying the impact of potential therapeutic interventions. Based in San Francisco, California, the company received a $3.20M grant investment on 01 October 2019 from CARB-X. With its focus on precision medicine and cutting-edge technology, Trellis Bioscience is positioned to make significant contributions to the biotechnology and healthcare industries. This recent investment is a testament to the potential and value of the company's unique approach to cellular informatics.

Business keywords: cellular informatics, therapeutic antibody treatments, technology platform, monoclonal antibodies, cell biology platform, single cell level, cell types monitoring, therapeutic interventions, San Francisco, discovery platform

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $3.20M 1
CARB-X
CARB-X
01 Oct 2019
Debt Financing $235.00K -
09 Nov 2011
Venture Round $11.72M -
07 Aug 2009
Series B $10.00M 4
Easton Capital Novartis Venture Fund Morgenthaler Ventures
Easton Capital, Novartis Venture Fund +2
14 Feb 2007
Series A $3.43M -
02 Jan 2004

Trellis Bioscience Inc. Alternatives & Competitors

View All Alternatives
Trellis Bioscience Inc. vs
RevMAb Biosciences USA, Inc.
RevMAb Biosciences USA, Inc. United States

Antibody Manufacturer and Supplier | High-Quality Rabbit and Goat Monoclonal Antibodies

Venture round
2 employees
Biotechnology, Health Care
Trellis Bioscience Inc. vs
Ablexis, LLC
Ablexis, LLC United States

A superior, next generation transgenic platform.

Series A
1 employees
Biotechnology, Health Care
Trellis Bioscience Inc. vs
OncoResponse
OncoResponse United States

Interrogating for Cures

10 employees
Biopharma, Biotechnology
Also compare with: Trellis Bioscience Inc. vs Vevo Therapeutics Vevo Therapeutics View all alternatives

FAQ About Trellis Bioscience Inc.

Our human mAb TRL1068 disrupts bacterial biofilm and makes traditional antibiotics work again overcoming drug resistance
Trellis Bioscience Inc. was founded in 1998.
Trellis Bioscience Inc. is headquartered in Redwood City, United States.
Trellis Bioscience Inc. operates in Biotechnology, Health Care and Health and Wellness. Its work centres on cellular informatics, therapeutic antibody treatments, technology platform and monoclonal antibodies.
Trellis Bioscience Inc. has approximately 18 employees.
Trellis Bioscience Inc. has completed 5 funding rounds, raising a total of $28.58M. The latest funding stage is Grant.
Top alternatives and competitors to Trellis Bioscience Inc. include RevMAb Biosciences USA, Inc., Ablexis, LLC, OncoResponse, Vevo Therapeutics, Yumab GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Trellis Bioscience Inc. and RevMAb Biosciences USA, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Trellis Bioscience Inc., https://bouncewatch.com/company/trellis-bioscience, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout